“Existing technologies will not deliver the breakthrough performance required to realize the full potential of the DNA economy … something different, and truly innovative is required.”
— Paul Mola, CEO and Founder
The Story Behind Roswell
The name Roswell was inspired by the "out-of-this-world" disruptive and game-changing nature of our technology. Our technology is based on the most recent advances in chips and nanotechnology coupled with the always-evolving field of genomics. Before we established Roswell, our team was involved in creating and driving global adoption of sequencing technology to solve some of medicine's biggest challenges, yet we continually encountered the significant hurdles of high cost, workflow complexity and limited accuracy. We knew we'd have to think beyond current technology to finally enable the price point, turn-around time and accuracy needed to unlock the DNA economy. We have done just that.
Our Goal: Precision Medicine
Current prevention and treatment of disease is not precisely tailored to each individual's unique variability in genes, environment and lifestyle. Precision medicine should begin with complete knowledge of the individual's genome, however, current whole-genome DNA sequencing technology is still too costly, too complex and low accuracy to use in precision medicine at the population scale. Roswell's sequencing technology was specifically designed to disrupt the current technologies and deliver an "endgame" sequencing platform, ideal for the future of global precision medicine.